Results 261 to 270 of about 933,327 (380)

Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population [PDF]

, 2009
Uğur Hodoğlugil, David Williamson, Robert W. Mahley   +2 more
openalex   +1 more source

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

Circulation, 2000
Bezafibrate Infarction Prevention study
semanticscholar   +1 more source

Effects of Changes in Metabolic Syndrome Status on Cognitive Function: A 10‐Year Study in a Middle‐Aged Population

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The long‐term cumulative impact of metabolic syndrome (MS) on cognitive decline remains uncertain. This study investigated how changes in MS status over 10 years relate to cognition and whether sex modifies this relationship. A total of 766 participants (mean baseline age: 54 years) from the Kaohsiung Atherosclerosis Longitudinal Study were ...
Kelly Lim, Meng‐Ni Wu, Wei‐Chia Tsao, Wei‐Hao Lin, Suh‐Hang Hank Juo, Cheng‐Sheng Chen, Hsiu‐Fen Lin   +6 more
wiley   +1 more source

Causal effect of kimchi intake on HDL-cholesterol levels in middle aged Korean men: a two-sample Mendelian randomization analysis. [PDF]

Genes Nutr
Cha J, Ko SH, Shin D.
europepmc   +1 more source

Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia [PDF]

, 2004
Heidi E. Lilja, Elina Suviolahti, Aino Soro‐Paavonen, Tero Hiekkalinna, Aaron J. Day, Kenneth Lange, Eric M. Sobel, Marja‐Riitta Taskinen, Leena Peltonen, Markus Perola, Päivi Pajukanta   +10 more
openalex   +1 more source

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid‐Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis

Lipids, EarlyView.
ABSTRACT Ischemic stroke is frequently associated with symptomatic intracranial atherosclerotic stenosis (sICAS), is a leading cause of global disability and mortality. Current guidelines recommend dual antiplatelet and intensive statin therapies. Proprotein convertase subtilisin 9/kexin type 9 (PCSK9) inhibitors have emerged as a potent lipid‐lowering
Chao Zhao, Nuan Wang, Di Shi, Hao Zhou, Dan Chen, Guofang Chen   +5 more
wiley   +1 more source

HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome. [PDF]

Antioxidants (Basel)
Alcover S, Ramos-Regalado L, Girón G, Muñoz-García N, Vilahur G.   +4 more
europepmc   +1 more source

Changes in Plasma Sphingolipid Metabolites Following Roux‐En‐Y Gastric Bypass in Women With Obesity and Type 2 Diabetes: A Pilot Metabolomic Cohort Study

Lipids, EarlyView.
ABSTRACT Although sphingolipids are key players in lipotoxicity and metabolic diseases, their response to bariatric surgery and their relation to metabolic improvement remain unclear. This pilot study investigated plasma sphingolipid remodeling after Roux‐en‐Y gastric bypass (RYGB) and its associations with clinical and biochemical markers of ...
Gabriela de Oliveira Lemos, Raquel Susana Torrinhas, Natasha Mendonça Machado, Dan Linetzky Waitzberg   +3 more
wiley   +1 more source

Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non-HDL Cholesterol and Carotid Plaque. [PDF]

JACC Asia
Wang J, Zhao X, Zhao Y, Jin R, Li Y, Wang J, Liu Y, Wu Z, Guo X, Tao L.   +9 more
europepmc   +1 more source

Association between variations in the gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol-12

, 2011
Melanie Kolz, Baumert Jens, Müller Martina, Natalie Khuseyinova, Klopp Norman, Barbara Thorand, Meisinger Christine, Herder Christian, Koenig Wolfgang, Thomas Illig   +9 more
openalex   +1 more source